Semiwiki on LinkedIn Semiwiki on Facebook Semiwiki on Twitter Register / Log in 
Array
(
    [content] => 
    [params] => Array
        (
            [0] => /forum/threads/acl-digital-acquires-a-us-based-cro-symbiance-to-expand-and-scale-its-clinical-research-capabilities.23884/
        )

    [addOns] => Array
        (
            [DL6/MLTP] => 13
            [Hampel/TimeZoneDebug] => 1000070
            [SV/ChangePostDate] => 2010200
            [SemiWiki/Newsletter] => 1000010
            [SemiWiki/WPMenu] => 1000010
            [SemiWiki/XPressExtend] => 1000010
            [ThemeHouse/XLink] => 1000970
            [ThemeHouse/XPress] => 1010570
            [XF] => 2030770
            [XFI] => 1060170
        )

    [wordpress] => /var/www/html
)

ACL Digital Acquires a US-based CRO, Symbiance, to Expand and Scale its Clinical Research Capabilities

ACL Digital

ACL Digital

New member
1761548540877.pngThe strategic acquisition of Symbiance strengthens ACL Digital’s footprint in the Clinical research sector, offering AI-driven clinical research, CRO, and pharmacovigilance solutions, and its commitment to drive digital transformation for global pharmaceutical, biotech, and medical device companies.

Santa Clara, CA, and Bangalore, India, September 26, 2025: ACL Digital, a global leader in digital product innovation and engineering services, has announced the acquisition of Symbiance, a data-driven, technology-enabled Contract Research Organization (CRO) with over three decades of proven expertise in clinical data services and operations, medical monitoring, project management, medical writing, and pharmacovigilance segments.

The acquisition of Symbiance by ACL Digital solidifies its position as an end-to-end provider of clinical research and data CRO solutions on a global scale. It also strengthens ACL Digital’s overall Life Sciences portfolio by integrating deep domain expertise in clinical data management, data standardization, biostatistics, statistical programming, medical writing and pharmacovigilance.
 
You must log in or register to reply here.
Back
Top